Articles related to BLEPHARITIS

“Recurrent or non-resolving ‘chalazia’ are among the most common masquerades of sebaceous carcinoma, highlighting the need for histopathological evaluation.” — Bhawan Minhas, OD

As vision professionals, it’s crucial to stay informed about trending health practices on social media platforms like TikTok. Recently, a trend involving the application of castor oil around the eyes has gained popularity. Although one small study shows potential benefits in treating blepharitis, ophthalmologists warn against this practice due to potential risks.

The study provides valuable insights into the effectiveness of various questionnaires used to diagnose ocular neuropathic pain. It highlights the need for further research to determine the most appropriate questionnaire for this purpose.

Xdemvy, backed by robust clinical trials, offers a new, targeted treatment option for Demodex blepharitis. The FDA-approved solution is expected to be available by the end of August 2023.

As the optometry field advances, newer, more innovative medications are being introduced for the management of dry eye disease and Demodex blepharitis. These developments pave the way for more personalized and successful patient care.